MYC and cancer: Subsequent Gene Set Variation Analysis (GSVA) indicated stronger proliferative activity in these subclusters, with C3/C5 exhibiting higher scores in cancer-related pathways—including E2F targets, G2M checkpoint, and MYC targets V2—compared to other subclusters (Figure 5C).